|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 8507 |
FusionGeneSummary for CRLS1_CES5A |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CRLS1_CES5A | Fusion gene ID: 8507 | Hgene | Tgene | Gene symbol | CRLS1 | CES5A | Gene ID | 54675 | 221223 |
| Gene name | cardiolipin synthase 1 | carboxylesterase 5A | |
| Synonyms | C20orf155|CLS|CLS1|GCD10|dJ967N21.6 | CAUXIN|CES4C1|CES5|CES7|HEL126 | |
| Cytomap | 20p12.3 | 16q12.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | cardiolipin synthase (CMP-forming) | carboxylesterase 5Acarboxylesterase 5carboxylesterase 7carboxylesterase-like urinary excreted protein homologepididymis luminal protein 126 | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | Q9UJA2 | Q6NT32 | |
| Ensembl transtripts involved in fusion gene | ENST00000378863, ENST00000452938, ENST00000378868, ENST00000464921, | ENST00000521992, ENST00000541580, ENST00000319165, ENST00000518005, ENST00000290567, ENST00000520435, | |
| Fusion gene scores | * DoF score | 6 X 6 X 5=180 | 2 X 2 X 1=4 |
| # samples | 6 | 2 | |
| ** MAII score | log2(6/180*10)=-1.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/4*10)=2.32192809488736 | |
| Context | PubMed: CRLS1 [Title/Abstract] AND CES5A [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | BRCA | TCGA-A2-A0CL-01A | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000378863 | ENST00000521992 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 5CDS-intron | ENST00000378863 | ENST00000541580 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 5CDS-intron | ENST00000378863 | ENST00000319165 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 5CDS-intron | ENST00000378863 | ENST00000518005 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 5CDS-intron | ENST00000378863 | ENST00000290567 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 5CDS-intron | ENST00000378863 | ENST00000520435 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 3UTR-3CDS | ENST00000452938 | ENST00000521992 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 3UTR-intron | ENST00000452938 | ENST00000541580 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 3UTR-intron | ENST00000452938 | ENST00000319165 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 3UTR-intron | ENST00000452938 | ENST00000518005 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 3UTR-intron | ENST00000452938 | ENST00000290567 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 3UTR-intron | ENST00000452938 | ENST00000520435 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| Frame-shift | ENST00000378868 | ENST00000521992 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 5CDS-intron | ENST00000378868 | ENST00000541580 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 5CDS-intron | ENST00000378868 | ENST00000319165 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 5CDS-intron | ENST00000378868 | ENST00000518005 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 5CDS-intron | ENST00000378868 | ENST00000290567 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 5CDS-intron | ENST00000378868 | ENST00000520435 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| In-frame | ENST00000464921 | ENST00000521992 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 5CDS-intron | ENST00000464921 | ENST00000541580 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 5CDS-intron | ENST00000464921 | ENST00000319165 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 5CDS-intron | ENST00000464921 | ENST00000518005 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 5CDS-intron | ENST00000464921 | ENST00000290567 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
| 5CDS-intron | ENST00000464921 | ENST00000520435 | CRLS1 | chr20 | 6015201 | + | CES5A | chr16 | 55903656 | - |
Top |
FusionProtFeatures for CRLS1_CES5A |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CRLS1 | CES5A |
| Catalyzes the synthesis of cardiolipin (CL)(diphosphatidylglycerol) by specifically transferring aphosphatidyl group from CDP-diacylglycerol to phosphatidylglycerol(PG). CL is a key phospholipid in mitochondrial membranes andplays important roles in maintaining the functional integrity anddynamics of mitochondria under both optimal and stress conditions.{ECO:0000269|PubMed:16547353, ECO:0000269|PubMed:16678169}. | Involved in the detoxification of xenobiotics and in theactivation of ester and amide prodrugs. {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CRLS1_CES5A |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_CRLS1_ENST00000464921_chr20_6015201_+_CES5A_ENST00000521992_chr16_55903656_-_671aa EKDENKFFGLYVNXRVEGKSKLISTXIYVHXTXICVYLFCHIFVLFYFYYFIYFVLLYFVLLYCFWFTIWXILISGLSQFLEYSVKFTVF SVKTYSVDVNHFXYVNDFMNYFPLMLIKLVHDVWLCGLCDLCYSYSALLLXCESSHRKYLNYSTYLHDHFERCNVDCCCFLCQIPNSSNT TNTCQVFQSLLCHCXVKTNIHQQGEYSSPVNLGGSFFGSSSFQLCXQHLSSDTMVLVWFPGGAFKTGSASIFDGSALAAYEDVLVVVVQY RLGIFGFFTTWDQHAPGNWAFKDQVAALSWVQKNIEFFGGDPSSVTIFGESAGAISVSSLILSPMAKGLFHKAIMESGVAIIPYLEAHDY EKSEDLQVVAHFCGNNASDSEALLRCLRTKPSKELLTLSQKTKSFTRVVDGAFFPNEPLDLLSQKAFKAIPSIIGVNNHECGFLLPMKEA PEILSGSNKSLALHLIQNILHIPPQYLHLVANEYFHDKHSLTEIRDSLLDLLGDVFFVVPALITARYHRDAGAPVYFYEFRHRPQCFEDT KPAFVKADHADEVRFVFGGAFLKGDIVMFEGATEEEKLLSRKMMKYWATFARTGNPNGNDLSLWPAYNLTEQYLQLDLNMSLGQRLKEPR |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_CRLS1_ENST00000464921_chr20_6015201_+_CES5A_ENST00000521992_chr16_55903656_-_2013nt GAGAAGGATGAAAACAAATTCTTTGGCTTATATGTTAATTAGAGAGTGGAAGGCAAATCCAAGTTAATTTCTACTTAGATTTATGTCCAC TGAACTTAGATCTGTGTGTATTTGTTCTGCCACATTTTTGTATTATTTTATTTTTATTATTTTATTTATTTTGTATTATTATATTTTGTA TTATTATATTGTTTCTGGTTTACCATCTGGTAAATTCTTATTTCTGGTTTAAGTCAATTTCTAGAATATTCTGTTAAGTTTACCGTTTTC AGTGTAAAAACCTATAGTGTTGATGTTAACCATTTTTAATATGTAAACGATTTTATGAACTATTTCCCTTTAATGCTAATAAAACTTGTC CATGATGTCTGGCTTTGTGGGCTATGTGATCTCTGTTACAGCTACTCAGCTCTGCTGTTGTAGTGTGAAAGCAGCCACAGAAAATATTTA AATTATTCCACTTACTTACATGATCATTTCGAGAGATGTAATGTTGATTGCTGCTGTTTTTTATGTCAGATACCGAACTCTTCCAACACC ACGAACACTTGCCAAGTATTTCAATCCTTGCTATGCCACTGCTAGGTTAAAACCAACATTCATCAGCAAGGTGAATACAGCAGTCCAGTT AATCTTGGTGGCAGCTTCTTTGGCAGCTCCAGTTTTCAACTATGCTGACAGCATTTATCTTCAGATACTATGGTCTTGGTGTGGTTCCCA GGAGGTGCCTTCAAGACTGGCTCAGCCTCCATCTTTGATGGGTCCGCCCTGGCTGCCTATGAGGACGTGCTGGTTGTGGTCGTCCAGTAC CGGCTAGGAATATTTGGTTTCTTCACCACATGGGATCAGCATGCTCCGGGGAACTGGGCCTTCAAGGACCAGGTGGCTGCTCTGTCCTGG GTCCAGAAGAACATCGAGTTCTTCGGTGGGGACCCCAGCTCTGTGACCATCTTTGGCGAGTCCGCGGGAGCCATAAGTGTTTCTAGTCTT ATACTGTCTCCCATGGCCAAAGGCTTATTCCACAAAGCCATCATGGAGAGTGGGGTGGCCATCATCCCTTACCTGGAGGCCCATGATTAT GAGAAGAGTGAGGACCTGCAGGTGGTTGCACATTTCTGTGGTAACAATGCGTCAGACTCTGAGGCCCTGCTGAGGTGCCTGAGGACAAAA CCCTCCAAGGAGCTGCTGACCCTCAGCCAGAAAACAAAGTCTTTCACTCGAGTGGTTGATGGTGCTTTCTTTCCTAATGAGCCTCTAGAT CTATTGTCTCAGAAAGCATTTAAAGCAATTCCTTCCATCATCGGAGTCAATAACCACGAGTGTGGCTTCCTGCTGCCTATGAAGGAGGCT CCTGAGATCCTCAGTGGCTCCAACAAGTCCCTTGCCCTCCATCTGATACAAAACATCCTGCACATCCCGCCTCAGTATTTGCACCTTGTG GCTAATGAATACTTCCATGACAAGCACTCCCTGACTGAAATCCGAGACAGTCTTCTGGACTTGCTTGGAGATGTGTTCTTTGTGGTCCCT GCACTGATCACAGCTCGATATCACAGAGATGCTGGTGCACCTGTCTACTTCTATGAGTTTCGGCACCGGCCTCAGTGCTTTGAAGACACG AAGCCAGCTTTTGTCAAAGCCGACCACGCTGATGAAGTCCGCTTTGTGTTCGGTGGTGCCTTCCTGAAGGGGGACATTGTTATGTTCGAA GGAGCCACGGAGGAGGAGAAGTTACTGAGCCGGAAGATGATGAAATACTGGGCTACCTTTGCTCGAACCGGGAATCCTAATGGGAACGAC CTGTCTCTGTGGCCAGCTTATAATCTGACTGAGCAGTACCTCCAGCTGGACTTGAACATGAGCCTCGGACAGAGACTCAAAGAACCGCGG GTGGATTTTTGGACCAGCACCATCCCCCTGATCCTGTCTGCCTCCGACATGCTCCACAGTCCTCTTTCTTCCTTAACTTTCCTCTCTCTC |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_CRLS1_ENST00000464921_chr20_6015201_+_CES5A_ENST00000521992_chr16_55903656_-_2310nt GAGAAGGATGAAAACAAATTCTTTGGCTTATATGTTAATTAGAGAGTGGAAGGCAAATCCAAGTTAATTTCTACTTAGATTTATGTCCAC TGAACTTAGATCTGTGTGTATTTGTTCTGCCACATTTTTGTATTATTTTATTTTTATTATTTTATTTATTTTGTATTATTATATTTTGTA TTATTATATTGTTTCTGGTTTACCATCTGGTAAATTCTTATTTCTGGTTTAAGTCAATTTCTAGAATATTCTGTTAAGTTTACCGTTTTC AGTGTAAAAACCTATAGTGTTGATGTTAACCATTTTTAATATGTAAACGATTTTATGAACTATTTCCCTTTAATGCTAATAAAACTTGTC CATGATGTCTGGCTTTGTGGGCTATGTGATCTCTGTTACAGCTACTCAGCTCTGCTGTTGTAGTGTGAAAGCAGCCACAGAAAATATTTA AATTATTCCACTTACTTACATGATCATTTCGAGAGATGTAATGTTGATTGCTGCTGTTTTTTATGTCAGATACCGAACTCTTCCAACACC ACGAACACTTGCCAAGTATTTCAATCCTTGCTATGCCACTGCTAGGTTAAAACCAACATTCATCAGCAAGGTGAATACAGCAGTCCAGTT AATCTTGGTGGCAGCTTCTTTGGCAGCTCCAGTTTTCAACTATGCTGACAGCATTTATCTTCAGATACTATGGTCTTGGTGTGGTTCCCA GGAGGTGCCTTCAAGACTGGCTCAGCCTCCATCTTTGATGGGTCCGCCCTGGCTGCCTATGAGGACGTGCTGGTTGTGGTCGTCCAGTAC CGGCTAGGAATATTTGGTTTCTTCACCACATGGGATCAGCATGCTCCGGGGAACTGGGCCTTCAAGGACCAGGTGGCTGCTCTGTCCTGG GTCCAGAAGAACATCGAGTTCTTCGGTGGGGACCCCAGCTCTGTGACCATCTTTGGCGAGTCCGCGGGAGCCATAAGTGTTTCTAGTCTT ATACTGTCTCCCATGGCCAAAGGCTTATTCCACAAAGCCATCATGGAGAGTGGGGTGGCCATCATCCCTTACCTGGAGGCCCATGATTAT GAGAAGAGTGAGGACCTGCAGGTGGTTGCACATTTCTGTGGTAACAATGCGTCAGACTCTGAGGCCCTGCTGAGGTGCCTGAGGACAAAA CCCTCCAAGGAGCTGCTGACCCTCAGCCAGAAAACAAAGTCTTTCACTCGAGTGGTTGATGGTGCTTTCTTTCCTAATGAGCCTCTAGAT CTATTGTCTCAGAAAGCATTTAAAGCAATTCCTTCCATCATCGGAGTCAATAACCACGAGTGTGGCTTCCTGCTGCCTATGAAGGAGGCT CCTGAGATCCTCAGTGGCTCCAACAAGTCCCTTGCCCTCCATCTGATACAAAACATCCTGCACATCCCGCCTCAGTATTTGCACCTTGTG GCTAATGAATACTTCCATGACAAGCACTCCCTGACTGAAATCCGAGACAGTCTTCTGGACTTGCTTGGAGATGTGTTCTTTGTGGTCCCT GCACTGATCACAGCTCGATATCACAGAGATGCTGGTGCACCTGTCTACTTCTATGAGTTTCGGCACCGGCCTCAGTGCTTTGAAGACACG AAGCCAGCTTTTGTCAAAGCCGACCACGCTGATGAAGTCCGCTTTGTGTTCGGTGGTGCCTTCCTGAAGGGGGACATTGTTATGTTCGAA GGAGCCACGGAGGAGGAGAAGTTACTGAGCCGGAAGATGATGAAATACTGGGCTACCTTTGCTCGAACCGGGAATCCTAATGGGAACGAC CTGTCTCTGTGGCCAGCTTATAATCTGACTGAGCAGTACCTCCAGCTGGACTTGAACATGAGCCTCGGACAGAGACTCAAAGAACCGCGG GTGGATTTTTGGACCAGCACCATCCCCCTGATCCTGTCTGCCTCCGACATGCTCCACAGTCCTCTTTCTTCCTTAACTTTCCTCTCTCTC CTCCAGCCTTTCTTTTTCTTTTGTGCTCCTTGAGAAGTTATCTTTCTGTGATTTTGGTTTCCCTTCTCCTCCCATAATTTCTCCCGCAAT CATTAGCTTCTTTCTGAGCTCAGCTGCTTTCTATGGGGATCCTTGCAAAACAAGCTGCTTTCGCTGATATTTTATGGACTTAGGAATGAT CCTTACAGAATTCTTTTCAACATCAAAAAGTGCAATTTGTCTTGGAAGGCAACAAGATTTCTTCAATAAATTTGGAAGAGGGCTGGCCTA |
Top |
FusionGenePPI for CRLS1_CES5A |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| CRLS1 | FBXO15, PINK1 | CES5A |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CRLS1_CES5A |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CRLS1_CES5A |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|